Home > Insider Trading > Filing (0000919574-13-006382)

Filing Details

Accession Number:: 0000919574-13-006382
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-11-13 19:15:35
Reporting Period:: 2013-11-11

Filing Date:: 2013-11-13
Accepted Time:: 2013-11-13 19:15:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
891288	Questcor Pharmaceuticals Inc	QCOR	Pharmaceutical Preparations (2834)	330476164

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1278386	Broadwood Partners Lp	C/O Broadwood Capital Inc. 724 Fifth Avenue, 9Th Floor New York NY 10019	Yes	No	No	No
1278387	Broadwood Capital Inc	724 Fifth Avenue, 9Th Floor New York NY 10019	Yes	No	No	No
1278388	C Neal Bradsher	C/O Broadwood Capital Inc. 724 Fifth Avenue, 9Th Floor New York NY 10019	Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-11-11	130,122	$62.25	3,166,538	No	4	S	Direct
Common Stock	Disposition	2013-11-11	0	$0.00	3,166,538	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2013-11-12	195,844	$62.28	2,970,694	No	4	S	Direct
Common Stock	Disposition	2013-11-12	0	$0.00	2,970,694	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2013-11-13	174,034	$62.56	2,796,660	No	4	S	Direct
Common Stock	Disposition	2013-11-13	0	$0.00	2,796,660	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	See Footnote
No	4	S	Direct
No	4	S	Indirect	See Footnote
No	4	S	Direct
No	4	S	Indirect	See Footnote

Footnotes

This constitutes the weighted average purchase price. The prices range from $61.85 to $62.52. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
This constitutes the weighted average purchase price. The prices range from $61.67 to $62.97. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
This constitutes the weighted average purchase price. The prices range from $62.15 to $62.83. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
These securities are owned by Broadwood Partners, L.P., which is a Reporting Person.
The reported securities are directly owned by Broadwood Partners, L.P. and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners, L.P. and Neal C. Bradsher as President of Broadwood Capital, Inc. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.